Lessons From A Post-Authorisation Study Of Rivaroxaban Use And Potential Adverse Outcomes In Routine Practice In Four Countries
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY(2021)
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY(2021)